1. Market Research
  2. > Tobacco Market Trends
  3. > Smoking Cessation - Data, Analysis and Forecasts to 2023

Smoking Cessation - Data, Analysis and Forecasts to 2023

  • October 2013
  • -
  • GMR Data Ltd
  • -
  • 101 pages

GMR Data’s new pharmaceutical report outlines the factors affecting the global smoking cessation market across the forecast period 2013-2023. The report outlines key drivers and restraints of the market in all key global geographies.

Key drivers of the global smoking cessation market include;
Increased health care / health education in many geographies
Adoption of smoking cessation products onto health insurance policies
Increasing number of smoking cessation products emerging onto the market
Emergence of e-cigarettes onto the global market
Over 1bn smokers world wide

This report quantifies the market, in terms of each key geography; explaining which direction each key market will head across the next ten years, and why, with detailed financial forecasts. The report contains over 100 pages as well as 85 charts, graphs and tables detailing the market.

This report also breaks down the market in terms of current smoking cessation drugs and products that occupy the market at present; examining the key prescription and OTC drugs that drive the market. In addition to this crucial information this report offers analysis and opinion on current R&D in the smoking cessation sector alongside in depth analysis of the emerging, global e-cigarette market.


This report also includes 3 original, exclusive, interview transcripts with key global pharmaceutical companies;
Pfizer
Elder Pharmaceuticals
GlaxoSmithKline

Purchase this report today to find out where company features in todays market; find the key brands and products on the market and where they will be sold globally.

Table Of Contents

Smoking Cessation - Data, Analysis and Forecasts to 2023
1 Executive Summary

1.1. Smoking Cessation Market Review
1.2. Chapter Breakdown
1.3. Research and Analysis Methods

2 Introduction to Smoking Cessation

2.1. Smoking Cessation Treatment Overview
2.1.1. Nicotine Replacement Therapy (NRT)
2.1.2. Non-NRT Therapy
2.2. Global Tobacco Consumption Prevalence, Trends and Impact
2.2.1. Prevalence of Death Caused due to Tobacco
2.2.2. Second-Hand Smoking
2.2.3. Increased Awareness of Health Implications in Relation to Smoking
2.2.4. Enforcement of Bans on Tobacco Product Advertising and Promotions
2.2.5. Increased Taxation

3 Smoking Cessation Market Forecasts

3.1. Global Smoking Cessation Market
3.1.1. Global Smoking Cessation Market
3.1.2. Global Prescription Drugs Smoking Cessation Market

4 Key Global Smoking Cessation Markets 2013-2023

4.1. The US Smoking Cessation Market - Set to Occupy 45-50% of the Global Market Across 2013-2023
4.2. The UK Smoking Cessation Market - How Will This Mature Market Grow Through 2013-2023?
4.3. The France Smoking Cessation Market - How Much of the Global Smoking Cessation Market Will France Occupy to 2023?
4.4. The German Smoking Cessation Market - Will Reduced German Tobacco Consumption Drive the Smoking Cessation Market?
4.5. The Spanish Smoking Cessation Market - The Strictest Anti-Smoking Laws in the EU, How Will This Affect The Spanish Smoking Cessation Market?
4.6. The Italian Smoking Cessation Market - How Will Strong E-cigarette Sales Affect Other NRT Products in the Italian Smoking Cessation Market?
4.7. The Japanese Smoking Cessation Market - Why Does GMR Data Forecast a Low Growth Rate in the Japanese Smoking Cessation Market?
4.8. The Rest of World Smoking Cessation Market - How Will Emerging Markets, Such as India and China, Affect theGlobal Smoking Cessation Market Across 2013-2023?

5 Nicotine Replacement Therapies (NRT) Market

5.1. NicoDerm CQ
5.2. Nicotrol
5.3. Habitrol (Nicotinell)
5.4. Nicorette

6 Prescription Drugs Smoking Cessation Market

6.1. Chantix (by Pfizer): Varenicline
6.2. Zyban / Wellbutrin (by GSK): bupropion

7 Leading Companies in the Global Smoking Cessation Market

7.1. Pfizer
7.2. GlaxoSmithKline (GSK)
7.3. Novartis
7.4. Johnson and Johnson (JandJ)
7.5. Perrigo
7.6. Sophomore and Extab
7.7. 22nd Century Group, Inc.

8 SWOT Analysis of the Smoking Cessation Market

8.1. Strengths
8.1.1. FDA Relaxation in the NRT Market
8.1.2. Increased Insurance Cover for Smoking Cessation Products
8.1.3. Strong Mature Markets
8.2. Weaknesses
8.2.1. Weak RandD pipeline for the smoking cessation market
8.2.2. Side Effects to Current Drugs/Therapies on the Market
8.3. Opportunities
8.3.1. E-cigarettes
8.3.1.1. E-cigarettes Legal Status
8.3.1.2. E-cigarettes background
8.3.1.3. Geographic Breakdown and Market Share for E-cigarettes
8.3.1.4 Market Forecast
8.3.1.5 E-cigarette Industry Regulation
8.3.2. Future Research on Drugs/Therapies Currently on the Market
8.3.3. Strong Emerging Markets
8.4. Threats
8.4.1 Pool of Smokers Greatly Reduced in Some Key Markets
8.4.2 New Drug / Product threat

9 Expert Interviews

9.1. Pfizer
9.2. Elder Pharmaceuticals
9.3. GlaxoSmithKline



List of Tables

Table 2.2.1 Prevalence of tobacco use among adults in selected countries—males and females, 2010
Table 2.2.2: Non-Smoking Adults Working Indoors Who Are Exposed to Second-hand Tobacco Smoke, 2008 - 2010
Table 2.2.3: BRIC Population, GDP per Capita 2000 and 2010 ($/per annum)
Table 2.2.3.1: Smokers Reporting Six Months Continued Cessation with Different Interventions
Table 2.2.3.2: Adult Smokers Who Do Not Believe, or Do Not Know That Smoking Causes Specific Diseases, by Country
Table 3.1 Global Smoking Cessation Market Forecast 2013-2023 ($m)
Table 3.1.a: Key NRT Products Revenue Forecast 2013, 2018 and 2023 ($/m)
Table 3.1.b Global Smoking Cessation Market - Breakdown ($m)
Table 3.1.1 Global NRT Smoking Cessation Market Forecast 2013-2023 ($/m)
Table 3.1.2 Global Prescription Drugs Smoking Cessation Market Forecast 2013-2023 ($/m)
Table 4.a The Global Smoking Cessation Market Forecast 2012 -2023, by Country ($/m per annum)
Table 4.b Key Countries CAGR 2013-2023 (%)
Table 4.c Estimated Smoking Cessation Market Share for Selected Countries 2013, 2018 and 2023 (%)
Table 4.1 the US Smoking Cessation Market Forecast 2011-2023 ($/m)
Table 4.2 the UK Smoking Cessation Market Forecast 2012-2023 ($/m)
Table 4.2.1 EU5 Total Population and Population of Smokers 2012
Table 4.3 the France Smoking Cessation Market Forecast 2011-2023 ($ Million)
Table 4.4 the German Smoking Cessation Market Forecast 2011-2023 ($/m)
Table 4.4.1 Amount of Tobacco Sold in Germany 1995-2010 (Tonnes)
Table 4.5 the Spanish Smoking Cessation Market Forecast 2011-2023 ($ Million)
Table 4.5.1 The number of smokers in Spain (Million)
Table 4.6 The Italian Smoking Cessation Market Forecast 2011-2023 ($/m)
Table 4.7 the Japanese Smoking Cessation Market Forecast 2011-2023 ($/m)
Table 4.8 The Rest of the World Smoking Cessation Market Forecast 2011-2023 ($ Million)
Table 4.8.1 Estimated Smoking Cessation Market Share for Selected Countries 2013, 2018 and 2023 (%)
Table 4.8.2 BRIC Population, GDP 2000 and 2010, CAGR and GDP per Capita 2000 and 2010 ($/per annum)
Table 5.1 Market Forecast for Nicoderm CQ 2013-2023
Table 5.2 Global Nicotrol Market 2010-2012 ($m)
Table 5.2.1 Global Nicotrol Market Forecast 2013-2023 ($/m)
Table 5.3 Market Forecast for Habitrol/Nicotinell 2013-2023
Table 5.4 Market Forecast for Nicorette 2013-2023
Table 6 Tobacco Cessation Medications and Associated Side Effects
Table 6.1 Global Chantix/ Champix Market 2008 - 2012
Table 6.1.a Market Forecast for Chantix / Champix 2013-2023
Table 6.2 Market Forecast for Zyban 2013-2023
Table 7.1 Pfizer Smoking Cessation Pipeline
Table 7.2 Global Chantix / Champix Market 2008-2012
Table 7.3 Market Forecast for Chantix / Champix 2013-2023
Table 7.4 Market Forecast for Zyban 2013-2023
Table 8 SWOT Analysis
Table 8.1.3 US, UK, France and Japanese Smoking Cessation Markets 2012-2016 ($/ per annum)
Table 8.2.1 NRT Products Pipeline
Table 8.2.1.a Smoking Cessation Drugs /Products Pipeline
Table 8.2.2 Side Effects of major smoking cessation products
Table 8.3.1.2 Major E-cigarette Brands
Table 8.3.1.4 Market Forecast for E-Cigarettes 2013-2023
Table 8.3.1.4.a Costs per pack of cigarettes in Key countries
Table 8.3.3ROW Smoking Cessation Market Share 2013
Table 8.3.3.a Chinese and Indian Populations, Number of Smokers, GDP in 2000 and 2010 ($)



List of Figures

Figure 2.2.1: Prevalence of tobacco use among adults in selected countries—males and females, 2010
Figure 2.2.4.1 Global Market Size as per Skin Cancer Type - Incidences
Figure 2.2.2 Non-Smoking Adults Working Indoors Who Are Exposed to Second-hand Tobacco Smoke, 2008 - 2010
Figure 2.2.3 Adult Smokers Who Do Not Believe, or Do Not Know That Smoking Causes Specific Diseases, by Country
Chart 2.2.5: Average Retail Price and Taxation (Excise and Total) of Most Sold Brands of Cigarettes, 2010
Figure 3.1 Global Smoking Cessation Market Forecasts 2013 to 2023
Figure 3.1.1 Global NRT Smoking Cessation Market Forecast 2013-2023
Figure 3.1.1.a Global NRT Smoking Cessation Market Share by Product Type
Figure 3.1.2 Global Prescription Drugs Smoking Cessation Market Forecast 2013-2023
GMR Data 2013
Figure 4.a Global Market Share for Selected Countries 2013
Figure 4.b Global Market Share for Selected Countries 2018
Figure 4.c Global Market Share for Selected Countries 2023
Figure4.1. The US Smoking Cessation Market Forecast 2012-2023 ($/m)
Figure 4.2 Retail Sales of NRT Products in the UK 2012
Figure 4.2.a. The UK Smoking Cessation Market Forecast 2012-2023 ($ Million)
Figure 4.3. The France Smoking Cessation Market Forecast 2012-2023 ($ Million)
Figure 4.4 The German Smoking Cessation Market Forecast 2012-2023 ($ Million)
Figure 4.5. The Spanish Smoking Cessation Market Forecast 2012-2023 ($ Million)
Figure 4.6 The Italian Smoking Cessation Market Forecast 2012-2023 ($/m)
Figure 4.7 The Japanese Smoking Cessation Market Forecast 2012-2023 ($ Million)
Figure 4.8 The ROW Smoking Cessation Market Forecast 2012-2023 ($ Million)
Figure 5.1 Market Forecast for Nicoderm CQ 2013-2023
Figure 5.1.a Geographic Breakdown for Nicoderm CQ 2012 and 2023
Figure 5.2 Global Revenue for Nicotrol 2010-2012
Figure 5.2.1 Global Market Forecast for Nicotrol 2013-2023
Figure 5.3 Market Forecast for Habitrol/Nicotinell 2013-2023
Figure 5.4 Market Forecast for Nicorette 2013-2023
Figure 6.1 Global Chantix/ Champix Market 2008 - 2012
Figure 6.1.a Global Chantix/ Champix Market 2013 - 2023
Figure 6.1.b Geographic Breakdown for Chantix / Champix 2012 and 2023
Figure 6.2 Global Zyban Market 2013 - 2023
Figure 8.3.1.3 Geographic Breakdown
Figure 8.3.1.3.1 Market Share of e-cigarette Sales in the US Convenience Stores by Brand
Figure 8.3.1.4 Market Forecast for E-Cigarettes 2013-2023


Companies mentioned in this report;

22nd Century Group, Inc
Acrux
Alcon Inc
Altria Group Inc
Alza Corporation
American Lung Association and Cancer Advocacy Coalition of Canada
Aradigm Corporation
Biota Holdings Ltd
Biota Pharmaceuticals, Inc.
Birlaveda
British American Tobacco
Celtic Pharmaceuticals
Cipla
CN Creative
Cytos Biotechnology
Elder Pharmaceuticals limited
EverSmoke Electronic Cigarettes
Evotec AG
Extab Corporation
Frii Inc
GlaxoSmithKline
Green Smoke Inc
Imperial Tobacco
Independent Pharmaceutica AB
Institute of Human Behaviour and Allied Sciences
Invion Limited
Johnson and Johnson
KLOX Technologies
Lorillard Inc
McNeil
Nabi Biopharmaceuticals
NAL Pharmaceuticals
National Institute on Drug Abuse
Nicobrand
Niconovum AB
NJOY
Novartis
Nu Mark LLC
Perrigo
Pfizer Inc
Pure Cigs, LLC
Reynolds American Inc
RML Hospital and Chronic Care Foundation
Sandoz Pharmaceuticals
Selecta Biosciences, Inc
Shanghai Johnson and Johnson Pharmaceutical Ltd
Sopharma
South Beach Smoke
Sun Pharma
Taranabant, Merck and Co
Teva Pharmaceuticals
U.S. Preventive Services Task Force
University of Chicago
Vapor King
Volcano Fine Electronic Cigarettes
Watson Pharmaceuticals
White Cloud Electronic Cigarettes

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Opportunity in the Indian Lighters Market - 2016; Market size, Market share, Market landscape, Market trend analysis, Growth drivers, Future opportunity, Future forecast

Opportunity in the Indian Lighters Market - 2016; Market size, Market share, Market landscape, Market trend analysis, Growth drivers, Future opportunity, Future forecast

  • $ 4000
  • Industry report
  • April 2016
  • by Feedback Business Consulting

This report provides an insight into the Opportunity in the Indian Lighters current market scenario, structure and practices. In depth market scenario includes; - Current market size estimates, including ...

Smoking Tobacco in the US, 2015

Smoking Tobacco in the US, 2015

  • $ 1495
  • Industry report
  • February 2016
  • by Canadean Ltd

Summary The US smoking tobacco market is the smallest sector of the US tobacco products market, with a 5% share of the overall volume. However, it has recently been the most buoyant sector in the tobacco ...

Cigars & Cigarillos Market: Global Industry Analysis and Forecast 2015-2025

Cigars & Cigarillos Market: Global Industry Analysis and Forecast 2015-2025

  • $ 4900
  • Industry report
  • August 2016
  • by Persistence Market Research

Cigars & Cigarillos are produced by tightly rolling tobacco into tobacco leaves of varying thicknesses and lengths. The industry is driven by shifting young adult preference from cigarette to cigars & ...


ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.